<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(4)</volume><submitter>Morel JB</submitter><pubmed_abstract>&lt;b>Purpose&lt;/b>: To follow the evolution of peripheral ischemia by fluorescein angiography (FA) on ultra-wide-field (UWF) images in diabetic patients treated with anti-vascular endothelial growth factor (anti-VEGF) for macular edema. &lt;b>Methods&lt;/b>: Prospective, non-interventional cohort study analyzing UWF-FA images of 48 patients with diabetic retinopathy (48 eyes) treated for diabetic macular edema. UWF-FA was performed at baseline and after one year of anti-VEGF therapy (M12). The primary endpoint was the change in the non-perfusion index. &lt;b>Results&lt;/b>: Of the 48 patients included in this study, 25 completed the one-year follow-up, and 20 had FA images of sufficient quality to be interpreted. The non-perfusion index did not significantly change from baseline after one year of anti-VEG</pubmed_abstract><journal>Journal of clinical medicine</journal><pagination>1365</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9963628</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ultra-Wide-Field Fluorescein Angiography Assessment of Non-Perfusion in Patients with Diabetic Retinopathy Treated with Anti-Vascular Endothelial Growth Factor Therapy.</pubmed_title><pmcid>PMC9963628</pmcid><pubmed_authors>Giocanti-Auregan A</pubmed_authors><pubmed_authors>Amari F</pubmed_authors><pubmed_authors>Morel JB</pubmed_authors><pubmed_authors>Fajnkuchen F</pubmed_authors><pubmed_authors>Bloch-Queyrat C</pubmed_authors><pubmed_authors>Sritharan N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ultra-Wide-Field Fluorescein Angiography Assessment of Non-Perfusion in Patients with Diabetic Retinopathy Treated with Anti-Vascular Endothelial Growth Factor Therapy.</name><description>&lt;b>Purpose&lt;/b>: To follow the evolution of peripheral ischemia by fluorescein angiography (FA) on ultra-wide-field (UWF) images in diabetic patients treated with anti-vascular endothelial growth factor (anti-VEGF) for macular edema. &lt;b>Methods&lt;/b>: Prospective, non-interventional cohort study analyzing UWF-FA images of 48 patients with diabetic retinopathy (48 eyes) treated for diabetic macular edema. UWF-FA was performed at baseline and after one year of anti-VEGF therapy (M12). The primary endpoint was the change in the non-perfusion index. &lt;b>Results&lt;/b>: Of the 48 patients included in this study, 25 completed the one-year follow-up, and 20 had FA images of sufficient quality to be interpreted. The non-perfusion index did not significantly change from baseline after one year of anti-VEG</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T21:44:20.619Z</modification><creation>2025-04-04T21:44:20.619Z</creation></dates><accession>S-EPMC9963628</accession><cross_references><pubmed>36835902</pubmed><doi>10.3390/jcm12041365</doi></cross_references></HashMap>